Pfizer Inc. buy Guggenheim
Start price
18.03.25
/
50%
€24.09
Target price
18.03.26
-
Performance (%)
-7.80%
Price
21:54
€22.21
Summary
This prediction is currently active. With a performance of -7.80%, the BUY prediction for Pfizer Inc. by Guggenheim is down slightly. This prediction currently runs until 18.03.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 1.183% | 1.183% |
| iShares Core DAX® | 1.614% | -2.653% |
| iShares Nasdaq 100 | 2.191% | -0.704% |
| iShares Nikkei 225® | -0.459% | -3.230% |
| iShares S&P 500 | 2.385% | 0.248% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat